Photodynamic Therapy Market by product type, by devices, by application and by Region – Global Industry Analysis, Market Share, Trends, Size, and Forecasts to 2019 – 2027.


Global Photodynamic Therapy Market was valued US$ 1125.XX Mn in 2018 and is expected to reach US$ 17XX.XX Mn by 2027, at CAGR of 5.XX% during forecast period of 2019 to 2027.



 

To know about the Research Methodology :- Request Free Sample Report

The global photodynamic therapy market is emerging with huge attraction towards its therapy as it provides effective treatment process and minimal side effects. There are drastic advancement in medical research due to which the market is expanding into different treatment processes and becoming popular worldwide. Photodynamic therapy is cost effective, nominally painful and offers numerous advantages for cancer patients as it helps them to sidestep the chemotherapy or surgery.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

The photodynamic therapy involves the phototherapy treatment drugs and light therapy devices. Photodynamic therapy devices use the high-intensity bright light, which generate the dormant photosensitizer drugs when they are injected into the patient’s body. Among cancer patient popularity of light therapy is rising significantly which in turn drives the Photodynamic therapy market. Furthermore, photodynamic therapy is proved to be beneficial over chemotherapy as it can be repeated multiple times in one particular area.

The Global Photodynamic Therapy Market dynamics are thoroughly studied and explained in the report, which helps reader to understand emerging market trends, drivers, restraints, opportunities, and challenges at global and regional level for the Global Photodynamic Therapy Market.

scope of the report Global Photodynamic Therapy Market:Inquire before buying


Global Photodynamic Therapy Market is studied by Various Segments:

The analysts at Maximize Market Research have done an extensive research for the Global Photodynamic Therapy Market and provides the report with detail study of the market by various segments and by region:

• Global Photodynamic Therapy Market by Product Type

 Photosenitizer drugs

 Hematoporphyrin Derivative (Hpd)
 Aminolevulinic Acid (ALA)
 Benzoporphyrin Derivatives
 Texaphyrins
 Chlorins
 Dyes

• Global Photodynamic Therapy Market by Devices

 Disposable fiber optic light delivery devices
 Diode lasers

• Global Photodynamic Therapy Market by Application

 Basal Cell Carcinoma
 Actinic Keratosis
 Other

Photodynamic Therapy Market report is segmented on product type, by devices, by application and by regional & country level. Based upon product type, market is segmented by photodynamic drug which is further classified into Hematoporphyrin Derivative (HpD), Aminolevulinic Acid (ALA), benzoporphyrin derivatives, texaphyrins, chlorins and dyes. Segment Devices is divided into Disposable fiber optic light delivery devices and Diode lasers. Based upon application, photodynamic therapy market is classified into basal cell carcinoma, actinic keratosis and other.

Global Photodynamic Therapy Market Region wise Market Analysis & Forecast:

The report covers a geographic breakdown and a detailed analysis of each of the segments across region North America, Europe, Asia Pacific, and LAMEA.
• North America
 U.S.
 Canada
 Mexico
• Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Europe
• Asia Pacific
 Japan
 China
 India
 Rest of Asia-Pacific
• LAMEA
 Latin America
 Middle East
 Africa

The North American region is mounting in photodynamic therapy market due to rising number of skin cancers and increasing diagnostic facilities helping in detecting diseases at an early stage. The global photodynamic therapy market is evolving and expanding its reach in this region. The Europe market is experiencing growth due to increasing cases of cosmological disorder. The growing population and dermatological cases in many countries from region Asia Pacific is supplementing the photodynamic therapy market.

Global Photodynamic Therapy Market: Competition Landscape

The Global Photodynamic Therapy Market has the presence of a large number of players. Major players in the Global Photodynamic Therapy Market are concentrating on developing new technologies to facilitate the industry with lowest time and low expenditure consuming technologies. In the recent years there are many discoveries in the field of technologies with regards to Global Photodynamic Therapy Market, which in turn will help the industry to grow resulting in boost to the competition too. Detailed analysis of competition, new entrants, strategic alliances, mergers and acquisition in the Global Photodynamic Therapy Market is covered in the report. The report covers the market leaders and followers in the industry with the market dynamics by region. It will also help to understand the position of each player in the market by region, by segment with their expansion plans, R&D expenditure and organic & in-organic growth strategies. Long term association, strategic alliances, supply chain agreement and mergers & acquisition activities are covered in the report in detail from 2014 to 2019. Expected alliances and agreement in forecast period will give future course of action in the market to the readers. All major & important players are profiled, benchmarked in the report on different parameters that will help reader to gain insight about the market in minimum time.

Global Photodynamic Therapy Market Company Profiles –

The major players operating in the Global Photodynamic Therapy Market, analyzed in the report are:
• Sun Pharmaceutical Industries Ltd.
• Hologic, Inc.
• Allergan Plc.
• Galderma SA
• Quest PharmaTech Inc.
• Biofrontera AG
• anofi
• DUSA Pharmaceuticals
• Bausch Health
• Beiersdorf
• Soligenix
• Theralase Technologies
• Quest Pharmatech
• Galderma
• Biofrontera
• Lumenis
• PhotoMedex
• Biolitec
• Ambicare Health
• Novartis AG
• Valeant Pharmaceuticals International, Inc.
• Lumibird
• Modulight, Inc.
• Suslaser.com

Global Photodynamic Therapy Market Objective of the Report:

The objective of the report is to present a comprehensive analysis of Global Photodynamic Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Photodynamic Therapy Market dynamics, structure by analyzing the market segments and project the Global Photodynamic Therapy Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Photodynamic Therapy Market make the report investor’s guide. 




Global Photodynamic Therapy Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Photodynamic Therapy Market Size, by Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Photodynamic Therapy Market Analysis and Forecast
6.1. Global Photodynamic Therapy Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Photodynamic Therapy Market Value Share Analysis, by Product Type
7.4. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Product Type
7.5. Global Photodynamic Therapy Market Analysis, by Product Type
7.6. Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type

8. Global Photodynamic Therapy Market Analysis and Forecast, by Devices
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Photodynamic Therapy Market Value Share Analysis, by Devices
8.4. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Devices
8.5. Global Photodynamic Therapy Market Analysis, by Devices
8.6. Global Photodynamic Therapy Market Attractiveness Analysis, by Devices

9. Global Photodynamic Therapy Market Analysis and Forecast, by Application
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Photodynamic Therapy Market Value Share Analysis, by Application
9.4. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Application
9.5. Global Photodynamic Therapy Market Analysis, by Application
9.6. Global Photodynamic Therapy Market Attractiveness Analysis, by Application

10. Global Photodynamic Therapy Market Analysis, by Region
10.1. Global Photodynamic Therapy Market Value Share Analysis, by Region
10.2. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Region
10.3. Global Photodynamic Therapy Market Attractiveness Analysis, by Region

11. North America Photodynamic Therapy Market Analysis
11.1. Key Findings
11.2. North America Photodynamic Therapy Market Overview
11.3. North America Photodynamic Therapy Market Value Share Analysis, by Product Type
11.4. North America Photodynamic Therapy Market Forecast, by Product Type
11.4.1. Photosenitizer drugs
11.4.1.1. Hematoporphyrin Derivative (Hpd)
11.4.1.2. Aminolevulinic Acid (ALA)
11.4.1.3. Benzoporphyrin Derivatives
11.4.1.4. Texaphyrins
11.4.1.5. Chlorins
11.4.1.6. Dyes
11.5. North America Photodynamic Therapy Market Value Share Analysis, by Devices
11.6. North America Photodynamic Therapy Market Forecast, by Devices
11.6.1. Disposable fiber optic light delivery devices
11.6.2. Diode lasers

11.7. North America Photodynamic Therapy Market Value Share Analysis, by Application
11.8. North America Photodynamic Therapy Market Forecast, by Application
11.8.1. Basal Cell Carcinoma
11.8.2. Actinic Keratosis
11.8.3. Others
11.9. North America Photodynamic Therapy Market Value Share Analysis, by Country
11.10. North America Photodynamic Therapy Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Photodynamic Therapy Market Analysis, by Country
11.12. U.S. Photodynamic Therapy Market Forecast, by Product Type
11.12.1. Photosenitizer drugs
11.12.1.1. Hematoporphyrin Derivative (Hpd)
11.12.1.2. Aminolevulinic Acid (ALA)
11.12.1.3. Benzoporphyrin Derivatives
11.12.1.4. Texaphyrins
11.12.1.5. Chlorins
11.12.1.6. Dyes
11.13. U.S. Photodynamic Therapy Market Forecast, by Devices
11.13.1. Disposable fiber optic light delivery devices
11.13.2. Diode lasers
11.14. U.S. Photodynamic Therapy Market Forecast, by Application
11.14.1. Basal Cell Carcinoma
11.14.2. Actinic Keratosis
11.14.3. Others
11.15. Canada Photodynamic Therapy Market Forecast, by Product Type
11.15.1. Photosenitizer drugs
11.15.1.1. Hematoporphyrin Derivative (Hpd)
11.15.1.2. Aminolevulinic Acid (ALA)
11.15.1.3. Benzoporphyrin Derivatives
11.15.1.4. Texaphyrins
11.15.1.5. Chlorins
11.15.1.6. Dyes
11.16. Steel Canada Photodynamic Therapy Market Forecast, by Devices
11.16.1. Disposable fiber optic light delivery devices
11.16.2. Diode lasers
11.17. Canada Photodynamic Therapy Market Forecast, by Application
11.17.1. Basal Cell Carcinoma
11.17.2. Actinic Keratosis
11.17.3. Others
11.18. North America Photodynamic Therapy Market Attractiveness Analysis
11.18.1. By Product Type
11.18.2. By Devices
11.18.3. By Application
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Photodynamic Therapy Market Analysis
12.1. Key Findings
12.2. Europe Photodynamic Therapy Market Overview
12.3. Europe Photodynamic Therapy Market Value Share Analysis, by Product Type
12.4. Europe Photodynamic Therapy Market Forecast, by Product Type
12.4.1. Photosenitizer drugs
12.4.1.1. Hematoporphyrin Derivative (Hpd)
12.4.1.2. Aminolevulinic Acid (ALA)
12.4.1.3. Benzoporphyrin Derivatives
12.4.1.4. Texaphyrins
12.4.1.5. Chlorins
12.4.1.6. Dyes
12.5. Europe Photodynamic Therapy Market Value Share Analysis, by Devices
12.6. Europe Photodynamic Therapy Market Forecast, by Devices
12.6.1. Disposable fiber optic light delivery devices
12.6.2. Diode lasers
12.7. Europe Photodynamic Therapy Market Value Share Analysis, by Application
12.8. Europe Photodynamic Therapy Market Forecast, by Application
12.8.1. Basal Cell Carcinoma
12.8.2. Actinic Keratosis
12.8.3. Others
12.9. Europe Photodynamic Therapy Market Value Share Analysis, by Country
12.10. Europe Photodynamic Therapy Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Photodynamic Therapy Market Analysis, by Country
12.12. Germany Photodynamic Therapy Market Forecast, by Product Type
12.12.1. Photosenitizer drugs
12.12.1.1. Hematoporphyrin Derivative (Hpd)
12.12.1.2. Aminolevulinic Acid (ALA)
12.12.1.3. Benzoporphyrin Derivatives
12.12.1.4. Texaphyrins
12.12.1.5. Chlorins
12.12.1.6. Dyes
12.13. Germany Photodynamic Therapy Market Forecast, by Devices
12.13.1. Disposable fiber optic light delivery devices
12.13.2. Diode lasers
12.14. Germany Photodynamic Therapy Market Forecast, by Application
12.14.1. Basal Cell Carcinoma
12.14.2. Actinic Keratosis
12.14.3. Others
12.15. U.K. Photodynamic Therapy Market Forecast, by Product Type
12.15.1. Photosenitizer drugs
12.15.1.1. Hematoporphyrin Derivative (Hpd)
12.15.1.2. Aminolevulinic Acid (ALA)
12.15.1.3. Benzoporphyrin Derivatives
12.15.1.4. Texaphyrins
12.15.1.5. Chlorins
12.15.1.6. Dyes
12.16. U.K. Photodynamic Therapy Market Forecast, by Devices
12.16.1. Disposable fiber optic light delivery devices
12.16.2. Diode lasers
12.17. U.K. Photodynamic Therapy Market Forecast, by Application
12.17.1. Basal Cell Carcinoma
12.17.2. Actinic Keratosis
12.17.3. Others
12.18. France Photodynamic Therapy Market Forecast, by Product Type
12.18.1. Photosenitizer drugs
12.18.1.1. Hematoporphyrin Derivative (Hpd)
12.18.1.2. Aminolevulinic Acid (ALA)
12.18.1.3. Benzoporphyrin Derivatives
12.18.1.4. Texaphyrins
12.18.1.5. Chlorins
12.18.1.6. Dyes
12.19. France Photodynamic Therapy Market Forecast, by Devices
12.19.1. Disposable fiber optic light delivery devices
12.19.2. Diode lasers
12.20. France Photodynamic Therapy Market Forecast, by Application
12.20.1. Basal Cell Carcinoma
12.20.2. Actinic Keratosis
12.20.3. Others
12.21. Italy Photodynamic Therapy Market Forecast, by Product Type
12.21.1. Photosenitizer drugs
12.21.1.1. Hematoporphyrin Derivative (Hpd)
12.21.1.2. Aminolevulinic Acid (ALA)
12.21.1.3. Benzoporphyrin Derivatives
12.21.1.4. Texaphyrins
12.21.1.5. Chlorins
12.21.1.6. Dyes
12.22. Italy Photodynamic Therapy Market Forecast, by Devices
12.22.1. Disposable fiber optic light delivery devices
12.22.2. Diode lasers
12.23. Italy Photodynamic Therapy Market Forecast, by Application
12.23.1. Basal Cell Carcinoma
12.23.2. Actinic Keratosis
12.23.3. Others
12.24. Spain Photodynamic Therapy Market Forecast, by Product Type
12.24.1. Photosenitizer drugs
12.24.1.1. Hematoporphyrin Derivative (Hpd)
12.24.1.2. Aminolevulinic Acid (ALA)
12.24.1.3. Benzoporphyrin Derivatives
12.24.1.4. Texaphyrins
12.24.1.5. Chlorins
12.24.1.6. Dyes
12.25. Spain Photodynamic Therapy Market Forecast, by Devices
12.25.1. Disposable fiber optic light delivery devices
12.25.2. Diode lasers
12.26. Spain Photodynamic Therapy Market Forecast, by Application
12.26.1. Basal Cell Carcinoma
12.26.2. Actinic Keratosis
12.26.3. Others
12.27. Rest of Europe Photodynamic Therapy Market Forecast, by Product Type
12.27.1. Photosenitizer drugs
12.27.1.1. Hematoporphyrin Derivative (Hpd)
12.27.1.2. Aminolevulinic Acid (ALA)
12.27.1.3. Benzoporphyrin Derivatives
12.27.1.4. Texaphyrins
12.27.1.5. Chlorins
12.27.1.6. Dyes
12.28. Rest of Europe Photodynamic Therapy Market Forecast, by Devices
12.28.1. Disposable fiber optic light delivery devices
12.28.2. Diode lasers
12.29. Rest Of Europe Photodynamic Therapy Market Forecast, by Application
12.29.1. Basal Cell Carcinoma
12.29.2. Actinic Keratosis
12.29.3. Others
12.30. Europe Photodynamic Therapy Market Attractiveness Analysis
12.30.1. By Product Type
12.30.2. By Devices
12.30.3. By Application
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments

13. Asia Pacific Photodynamic Therapy Market Analysis
13.1. Key Findings
13.2. Asia Pacific Photodynamic Therapy Market Overview
13.3. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Product Type
13.4. Asia Pacific Photodynamic Therapy Market Forecast, by Product Type
13.4.1. Photosenitizer drugs
13.4.1.1. Hematoporphyrin Derivative (Hpd)
13.4.1.2. Aminolevulinic Acid (ALA)
13.4.1.3. Benzoporphyrin Derivatives
13.4.1.4. Texaphyrins
13.4.1.5. Chlorins
13.4.1.6. Dyes
13.5. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Devices
13.6. Asia Pacific Photodynamic Therapy Market Forecast, by Devices
13.6.1. Disposable fiber optic light delivery devices
13.6.2. Diode lasers
13.7. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Application
13.8. Asia Pacific Photodynamic Therapy Market Forecast, by Application
13.8.1. Basal Cell Carcinoma
13.8.2. Actinic Keratosis
13.8.3. Others
13.9. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Country
13.10. Asia Pacific Photodynamic Therapy Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Photodynamic Therapy Market Analysis, by Country
13.12. China Photodynamic Therapy Market Forecast, by Product Type
13.12.1. Photosenitizer drugs
13.12.1.1. Hematoporphyrin Derivative (Hpd)
13.12.1.2. Aminolevulinic Acid (ALA)
13.12.1.3. Benzoporphyrin Derivatives
13.12.1.4. Texaphyrins
13.12.1.5. Chlorins
13.12.1.6. Dyes
13.13. China Photodynamic Therapy Market Forecast, by Devices
13.13.1. Disposable fiber optic light delivery devices
13.13.2. Diode lasers
13.14. China Photodynamic Therapy Market Forecast, by Application
13.14.1. Basal Cell Carcinoma
13.14.2. Actinic Keratosis
13.14.3. Others
13.15. India Photodynamic Therapy Market Forecast, by Product Type
13.15.1. Photosenitizer drugs
13.15.1.1. Hematoporphyrin Derivative (Hpd)
13.15.1.2. Aminolevulinic Acid (ALA)
13.15.1.3. Benzoporphyrin Derivatives
13.15.1.4. Texaphyrins
13.15.1.5. Chlorins
13.15.1.6. Dyes
13.16. India Photodynamic Therapy Market Forecast, by Devices
13.16.1. Disposable fiber optic light delivery devices
13.16.2. Diode lasers
13.17. India Photodynamic Therapy Market Forecast, by Application
13.17.1. Basal Cell Carcinoma
13.17.2. Actinic Keratosis
13.17.3. Others
13.18. Japan Photodynamic Therapy Market Forecast, by Product Type
13.18.1. Photosenitizer drugs
13.18.1.1. Hematoporphyrin Derivative (Hpd)
13.18.1.2. Aminolevulinic Acid (ALA)
13.18.1.3. Benzoporphyrin Derivatives
13.18.1.4. Texaphyrins
13.18.1.5. Chlorins
13.18.1.6. Dyes
13.19. Japan Photodynamic Therapy Market Forecast, by Devices
13.19.1. Disposable fiber optic light delivery devices
13.19.2. Diode lasers
13.20. Japan Photodynamic Therapy Market Forecast, by Application
13.20.1. Basal Cell Carcinoma
13.20.2. Actinic Keratosis
13.20.3. Others
13.21. ASEAN Photodynamic Therapy Market Forecast, by Product Type
13.21.1. Photosenitizer drugs
13.21.1.1. Hematoporphyrin Derivative (Hpd)
13.21.1.2. Aminolevulinic Acid (ALA)
13.21.1.3. Benzoporphyrin Derivatives
13.21.1.4. Texaphyrins
13.21.1.5. Chlorins
13.21.1.6. Dyes
13.22. ASEAN Photodynamic Therapy Market Forecast, by Devices
13.22.1. Disposable fiber optic light delivery devices
13.22.2. Diode lasers
13.23. ASEAN Photodynamic Therapy Market Forecast, by Application
13.23.1. Basal Cell Carcinoma
13.23.2. Actinic Keratosis
13.23.3. Others
13.24. Rest of Asia Pacific Photodynamic Therapy Market Forecast, by Product Type
13.24.1. Photosenitizer drugs
13.24.1.1. Hematoporphyrin Derivative (Hpd)
13.24.1.2. Aminolevulinic Acid (ALA)
13.24.1.3. Benzoporphyrin Derivatives
13.24.1.4. Texaphyrins
13.24.1.5. Chlorins
13.24.1.6. Dyes
13.25. Rest of Asia Pacific Photodynamic Therapy Market Forecast, by Devices
13.25.1. Disposable fiber optic light delivery devices
13.25.2. Diode lasers
13.26. Rest of Asia Pacific Photodynamic Therapy Market Forecast, by Application
13.26.1. Basal Cell Carcinoma
13.26.2. Actinic Keratosis
13.26.3. Others
13.27. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis
13.27.1. By Product Type
13.27.2. By Devices
13.27.3. By Application
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments

14. Middle East & Africa Photodynamic Therapy Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Photodynamic Therapy Market Overview
14.3. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Product Type
14.4. Middle East & Africa Photodynamic Therapy Market Forecast, by Product Type
14.4.1. Photosenitizer drugs
14.4.1.1. Hematoporphyrin Derivative (Hpd)
14.4.1.2. Aminolevulinic Acid (ALA)
14.4.1.3. Benzoporphyrin Derivatives
14.4.1.4. Texaphyrins
14.4.1.5. Chlorins
14.4.1.6. Dyes
14.5. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Devices
14.6. Middle East & Africa Photodynamic Therapy Market Forecast, by Devices
14.6.1. Disposable fiber optic light delivery devices
14.6.2. Diode lasers
14.7. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Application
14.8. Middle East & Africa Photodynamic Therapy Market Forecast, by Application
14.8.1. Basal Cell Carcinoma
14.8.2. Actinic Keratosis
14.8.3. Others
14.9. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Country
14.10. Middle East & Africa Photodynamic Therapy Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Photodynamic Therapy Market Analysis, by Country
14.12. GCC Photodynamic Therapy Market Forecast, by Product Type
14.12.1. Photosenitizer drugs
14.12.1.1. Hematoporphyrin Derivative (Hpd)
14.12.1.2. Aminolevulinic Acid (ALA)
14.12.1.3. Benzoporphyrin Derivatives
14.12.1.4. Texaphyrins
14.12.1.5. Chlorins
14.12.1.6. Dyes
14.13. GCC Photodynamic Therapy Market Forecast, by Devices
14.13.1. Disposable fiber optic light delivery devices
14.13.2. Diode lasers
14.14. GCC Photodynamic Therapy Market Forecast, by Application
14.14.1. Basal Cell Carcinoma
14.14.2. Actinic Keratosis
14.14.3. Others
14.15. South Africa Photodynamic Therapy Market Forecast, by Product Type
14.15.1. Photosenitizer drugs
14.15.1.1. Hematoporphyrin Derivative (Hpd)
14.15.1.2. Aminolevulinic Acid (ALA)
14.15.1.3. Benzoporphyrin Derivatives
14.15.1.4. Texaphyrins
14.15.1.5. Chlorins
14.15.1.6. Dyes
14.16. South Africa Photodynamic Therapy Market Forecast, by Devices
14.16.1. Disposable fiber optic light delivery devices
14.16.2. Diode lasers
14.17. South Africa Photodynamic Therapy Market Forecast, by Application
14.17.1. Basal Cell Carcinoma
14.17.2. Actinic Keratosis
14.17.3. Others
14.18. Rest of Middle East & Africa Photodynamic Therapy Market Forecast, by Product Type
14.18.1. Photosenitizer drugs
14.18.1.1. Hematoporphyrin Derivative (Hpd)
14.18.1.2. Aminolevulinic Acid (ALA)
14.18.1.3. Benzoporphyrin Derivatives
14.18.1.4. Texaphyrins
14.18.1.5. Chlorins
14.18.1.6. Dyes
14.19. Rest of Middle East & Africa Photodynamic Therapy Market Forecast, by Devices
14.19.1. Disposable fiber optic light delivery devices
14.19.2. Diode lasers
14.20. Rest of Middle East & Africa Photodynamic Therapy Market Forecast, by Application
14.20.1. Basal Cell Carcinoma
14.20.2. Actinic Keratosis
14.20.3. Others
14.21. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis
14.21.1. By Product Type
14.21.2. By Devices
14.21.3. By Application
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments

15. South America Photodynamic Therapy Market Analysis
15.1. Key Findings
15.2. South America Photodynamic Therapy Market Overview
15.3. South America Photodynamic Therapy Market Value Share Analysis, by Product Type
15.4. South America Photodynamic Therapy Market Forecast, by Product Type
15.4.1. Photosenitizer drugs
15.4.1.1. Hematoporphyrin Derivative (Hpd)
15.4.1.2. Aminolevulinic Acid (ALA)
15.4.1.3. Benzoporphyrin Derivatives
15.4.1.4. Texaphyrins
15.4.1.5. Chlorins
15.4.1.6. Dyes
15.5. South America Photodynamic Therapy Market Value Share Analysis, by Devices
15.6. South America Photodynamic Therapy Market Forecast, by Devices
15.6.1. Disposable fiber optic light delivery devices
15.6.2. Diode lasers
15.7. South America Photodynamic Therapy Market Value Share Analysis, by Application
15.8. South America Photodynamic Therapy Market Forecast, by Application
15.8.1. Basal Cell Carcinoma
15.8.2. Actinic Keratosis
15.8.3. Others

15.9. South America Photodynamic Therapy Market Value Share Analysis, by Country
15.10. South America Photodynamic Therapy Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Photodynamic Therapy Market Analysis, by Country
15.12. Brazil Photodynamic Therapy Market Forecast, by Product Type
15.12.1. Photosenitizer drugs
15.12.1.1. Hematoporphyrin Derivative (Hpd)
15.12.1.2. Aminolevulinic Acid (ALA)
15.12.1.3. Benzoporphyrin Derivatives
15.12.1.4. Texaphyrins
15.12.1.5. Chlorins
15.12.1.6. Dyes
15.13. Brazil Photodynamic Therapy Market Forecast, by Devices
15.13.1. Disposable fiber optic light delivery devices
15.13.2. Diode lasers
15.14. Brazil Photodynamic Therapy Market Forecast, by Application
15.14.1. Basal Cell Carcinoma
15.14.2. Actinic Keratosis
15.14.3. Others
15.15. Mexico Photodynamic Therapy Market Forecast, by Product Type
15.15.1. Photosenitizer drugs
15.15.1.1. Hematoporphyrin Derivative (Hpd)
15.15.1.2. Aminolevulinic Acid (ALA)
15.15.1.3. Benzoporphyrin Derivatives
15.15.1.4. Texaphyrins
15.15.1.5. Chlorins
15.15.1.6. Dyes
15.16. Mexico Photodynamic Therapy Market Forecast, by Devices
15.16.1. Disposable fiber optic light delivery devices
15.16.2. Diode lasers
15.17. Mexico Photodynamic Therapy Market Forecast, by Application
15.17.1. Basal Cell Carcinoma
15.17.2. Actinic Keratosis
15.17.3. Others
15.18. Rest of South America Photodynamic Therapy Market Forecast, by Product Type
15.18.1. Photosenitizer drugs
15.18.1.1. Hematoporphyrin Derivative (Hpd)
15.18.1.2. Aminolevulinic Acid (ALA)
15.18.1.3. Benzoporphyrin Derivatives
15.18.1.4. Texaphyrins
15.18.1.5. Chlorins
15.18.1.6. Dyes
15.19. Rest of South America Photodynamic Therapy Market Forecast, by Devices
15.19.1. Disposable fiber optic light delivery devices
15.19.2. Diode lasers

15.20. Rest of South America Photodynamic Therapy Market Forecast, by Application
15.20.1. Basal Cell Carcinoma
15.20.2. Actinic Keratosis
15.20.3. Other
15.21. South America Photodynamic Therapy Market Attractiveness Analysis
15.21.1. By Product Type
15.21.2. By Devices
15.21.3. By Application
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Sun Pharmaceutical Industries Ltd.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Company Footprint
16.3.2. Hologic, Inc.
16.3.3. Allergan Plc.
16.3.4. Galderma SA
16.3.5. Quest PharmaTech Inc.
16.3.6. Biofrontera AG
16.3.7. anofi
16.3.8. DUSA Pharmaceuticals
16.3.9. Bausch Health
16.3.10. Beiersdorf
16.3.11. Soligenix
16.3.12. Theralase Technologies
16.3.13. Quest Pharmatech
16.3.14. Galderma
16.3.15. Biofrontera
16.3.16. Lumenis
16.3.17. PhotoMedex
16.3.18. Biolitec
16.3.19. Ambicare Health
16.3.20. Novartis AG 
16.3.21. Valeant Pharmaceuticals International, Inc.
16.3.22. Lumibird
16.3.23. Modulight, Inc.
16.3.24. Suslaser.com

17. Primary Key Insights
  • INQUIRE BEFORE BUYING